ABBV Perry C Siatis sells $4.4M worth of shares
Mar 04, 2026, 5:32 AM
0.00%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
Perry C Siatis sold 18,668 shares of ABBV on 2 March at $235.26 per share, worth a total of $4.4M. They now own 17,510 ABBV shares, or a 80% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.